Predicting the risk of post-hepatectomy portal hypertension using a digital twin: A clinical proof of concept - Journal of Hepatology
Non-invasive assessment of portal hypertension by multi-parametric magnetic resonance imaging of the spleen: A proof of concept study
Should patients with clinically significant portal hypertension be on beta-blockers? | Liver Fellow Network
Non invasive evaluation of portal hypertension using transient elastography - ScienceDirect
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial - The Lancet
Clinical role of non-invasive assessment of portal hypertension
PDF) Clinically significant portal hypertension in chronic liver disease: Always cirrhosis?
Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease - Clinics in Liver Disease
Frontiers | Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis | Medicine
Solved In a crossover trial, 19 patients with clinically | Chegg.com
Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease - Clinics in Liver Disease
![PDF] Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/414e58b6473655b3badf54f966ef541e9887b77b/3-Table2-1.png "PDF] Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy | Semantic Scholar")
PDF] Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy | Semantic Scholar
Two-dimensional Shear Wave Elastography with Propagation Maps for the Assessment of Liver Fibrosis and Clinically Significant Portal Hypertension in Patients with Chronic Liver Disease: A Prospective Study - Academic Radiology
Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis - HPB
Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal Hypertension - Clinical Gastroenterology and Hepatology
Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension - The Lancet Gastroenterology & Hepatology
Serum keratin 19 (CYFRA21-1) links ductular reaction with portal hypertension and outcome of various advanced liver diseases | BMC Medicine | Full Text
Clinically significant portal hypertension in cirrhosis patients with COVID-19: Clinical characteristics and outcomes - Journal of Infection
Abbreviations: CSPH, clinical significant portal hypertension; APRI,... | Download Scientific Diagram
Cureus | Precision Onion Skinning Technique for Transjugular Intrahepatic Portosystemic Shunt Revision
The portal hypertension syndrome: etiology, classification, relevance, and animal models | Semantic Scholar
Juan Turnes on Twitter: "2/2 We can use #elastography rule of five + platelet count to identify those with clinically significant portal hypertension: ➡️ >25 kPa ➡️ 20-25 kPa & <150 platelets
Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension - JHEP Reports
